Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this study was to compare the clinical features and outcomes of ulcerative colitis (UC) according to the age of onset in Korea. Methods: A total of 1,141 patients who were diagnosed with UC between July 1987 and November 2013 at 11 tertiary hospitals were enrolled. The baseline disease characteristic and disease state at onset, treatment during the disease course were retrospectively reviewed among patients with young-onset (YO, < 20 years) and adult-onset (AO, ≥ 20 years). Severe outcome was defined as use of intravenous (IV) steroids, infliximab, immunosuppressant, or UC-related operation. Results: There were 55 YO patients (mean age, 17.8 ± 2.4) and 1,086 AO patients (mean age, 43.0 ± 13.6). High Mayo scores (7.7 ± 3.0 vs. 5.6 ± 2.7, p = 0.000), extensive UC (52.7% vs. 25.8%, p = 0.000) and IV steroid (41.8% vs. 18.0%, p = 0.000), immunosuppressant (47.3% vs. 26.9%, p = 0.002), and infliximab (20.0% vs. 7.2%, p = 0.001) use were more frequent in the YO than in the AO group. According to multivariate analysis, severe outcomes were related to YO disease (hazard ratio [HR], 2.18; 95% confidence interval [CI], 1.27 to 3.71), body mass index < 23 kg/m2 (HR, 1.46; 95% CI, 1.07 to 2.00), severe (HR, 2.29; 95% CI, 1.36 to 3.38), and moderate (HR, 2.48; 95% CI, 1.67 to 3.67) disease, extensive UC (HR, 2.90; 95% CI, 1.79 to 4.69), UC-related admission (HR, 63.89; 95% CI, 20.41 to 200.02), and oral steroid use (HR, 0.51; 95% CI, 0.39 to 0.67). Conclusions: UC with YO presented with more advanced clinical features at onset and more severe outcomes than the AO. YO cases require careful management and intense treatment strategies.
Abstract
Background/Aims: The aim of this study was to compare the clinical features and outcomes of ulcerative colitis (UC) according to the age of onset in Korea. Methods: A total of 1,141 patients who were diagnosed with UC between July 1987 and November 2013 at 11 tertiary hospitals were enrolled. The baseline disease characteristic and disease state at onset, treatment during the disease course were retrospectively reviewed among patients with young-onset (YO, < 20 years) and adult-onset (AO, ≥ 20 years). Severe outcome was defined as use of intravenous (IV) steroids, infliximab, immunosuppressant, or UC-related operation. Results: There were 55 YO patients (mean age, 17.8 ± 2.4) and 1,086 AO patients (mean age, 43.0 ± 13.6). High Mayo scores (7.7 ± 3.0 vs. 5.6 ± 2.7, p = 0.000), extensive UC (52.7% vs. 25.8%, p = 0.000) and IV steroid (41.8% vs. 18.0%, p = 0.000), immunosuppressant (47.3% vs. 26.9%, p = 0.002), and infliximab (20.0% vs. 7.2%, p = 0.001) use were more frequent in the YO than in the AO group. According to multivariate analysis, severe outcomes were related to YO disease (hazard ratio [HR], 2.18; 95% confidence interval [CI], 1.27 to 3.71), body mass index < 23 kg/m2 (HR, 1.46; 95% CI, 1.07 to 2.00), severe (HR, 2.29; 95% CI, 1.36 to 3.38), and moderate (HR, 2.48; 95% CI, 1.67 to 3.67) disease, extensive UC (HR, 2.90; 95% CI, 1.79 to 4.69), UC-related admission (HR, 63.89; 95% CI, 20.41 to 200.02), and oral steroid use (HR, 0.51; 95% CI, 0.39 to 0.67). Conclusions: UC with YO presented with more advanced clinical features at onset and more severe outcomes than the AO. YO cases require careful management and intense treatment strategies.
참고문헌 (35)
- Irvine EJ., "Quality of life of patients with ulcerative colitis:past, present, and future", Inflamm Bowel Dis, 14, pp.554~565 (2008)
- Cosnes J, "Epidemiology and natural history of inflammatory bowel diseases", Gastroenterology, 140, pp.1785~1794 (2011)
- Molodecky NA, "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review", Gastroenterology, 142, pp.46.e2~54.e2 (2012)
- Ng SC, "Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study", Gastroenterology, 145, pp.158.e2~165.e2 (2013)
- 양동훈, "한국인에서 궤양성 대장염은 증가하는가?", 대한내과학회지, 76(6), pp.637~642 (2009), 대한내과학회
- Lok KH, "Epidemiology and clinical characteristics of ulcerative colitis in Chinese population:experience from a single center in Hong Kong", J Gastroenterol Hepatol, 23, pp.406~410 (2008)
- Shin DH, "Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008", Dig Dis Sci, 56, pp.1154~1159 (2011)
- Sonnenberg A., "Age distribution of IBD hospitalization", Inflamm Bowel Dis, 16, pp.452~457 (2010)
- Kalkan IH, "Compar-ison of demographic and clinical characteristics of patients with early vs. adult vs. late onset ulcerative colitis", Eur J Intern Med, 24, pp.273~277 (2013)
- Leijonmarck CE, "Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study", Gut, 31, pp.329~333 (1990)
- Adamiak T, "Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study", Inflamm Bowel Dis, 19, pp.1218~1223 (2013)
- Zimmerman J, "Early and late onset ulcerative colitis: distinct clinical features", J Clin Gastroenterol, 7, pp.492~498 (1985)
- Brackmann S, "Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease", Scand J Gastroenterol, 44, pp.46~55 (2009)
- Bresci G, "Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up", Dig Liver Dis, 34, pp.419~423 (2002)
- Lee JH, "Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older?", Digestion, 81, pp.237~243 (2010)
- Lennard-Jones JE., "Classification of inflammatory bowel disease", Scand J Gastroenterol Suppl, 170, pp.2~6 (1989)
- Schroeder KW, "Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study", N Engl J Med, 317, pp.1625~1629 (1987)
- Silverberg MS, "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology", Can J Gastroenterol, 19(Suppl A), pp.5A~36A (2005)
- Hoie O, "Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort", Am J Gastroenterol, 102, pp.1692~1701 (2007)
- Bitton A, "Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis", Gastroenterology, 120, pp.13~20 (2001)
- Ha CY, "Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease", Clin Gastroenterol Hepatol, 8, pp.682.e1~687.e1 (2010)
- Ananthakrishnan AN, "Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations", Inflamm Bowel Dis, 15, pp.182~189 (2009)
- Winther KV, "Survival and cause-specific mortality in ulcerative colitis:follow-up of a population-based cohort in Copenhagen County", Gastroenterology, 125, pp.1576~1582 (2003)
- Prideaux L, "Inflammatory bowel disease in Asia: a systematic review", J Gastroenterol Hepatol, 27, pp.1266~1280 (2012)
- Hilmi I, "Demography and clinical course of ulcerative colitis in a multiracial Asian population: a nationwide study from Malaysia", J Dig Dis, 10, pp.15~20 (2009)
- Targownik LE, "The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort", Am J Gastroenterol, 107, pp.1228~1235 (2012)
- Aloi M, "Phenotype and disease course of early-onset pediatric inflammatory bowel disease", Inflamm Bowel Dis, 20, pp.597~605 (2014)
- Ekbom A, "Ulcerative proctitis in central Sweden 1965-1983: a population-based epidemiological study", Dig Dis Sci, 36, pp.97~102 (1991)
- Amador-Patarroyo MJ, "How does age at onset influence the outcome of autoimmune diseases?", Autoimmune Dis, 2012, pp.251730~ (2012)
- Grimm IS, "Inflammatory bowel disease in the elderly", Gastroenterol Clin North Am, 19, pp.361~389 (1990)
- Deal CL, "The clinical features of elderly-onset rheumatoid arthritis: a comparison with younger-onset disease of similar duration", Arthritis Rheum, 28, pp.987~994 (1985)
- Holtmann MH, "Significant differences between Crohn’s disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients", Dig Dis Sci, 55, pp.1066~1078 (2010)
- Bryant RV, "Systematic review: body composition in adults with inflammatory bowel disease", Aliment Pharmacol Ther, 38, pp.213~225 (2013)
- Romberg-Camps MJ, "Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease", Am J Gastroenterol, 104, pp.371~383 (2009)
- Roth LS, "Predictors of disease severity in ulcerative colitis patients from Southwestern Ontario", World J Gastroenterol, 16, pp.232~236 (2010)